SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Board declared a quarterly cash dividend on the Company's 5.875% Non-Cumulative Perpetual Preferred Stock, Series A, of $36.72 per share ($0.3672 per depository share), payable December 1, 2026.
View raw filing on EDGAR →SIGECO, a wholly-owned subsidiary of CenterPoint Energy, entered into a Bond Purchase Agreement on October 20, 2026, to issue $260 million in aggregate principal amount of first mortgage bonds across three series (Series 2026A for $130 million at 5.99% due 2031, Series 2026B for $80 million at 6.15% due 2033, and Series 2027A for $50 million at 6.33% due 2037), with proceeds designated for general corporate purposes including debt repayment and capital expenditures.
View raw filing on EDGAR →Metropolitan Bank Holding Corp. issued a press release on October 20, 2026 announcing third-quarter 2026 financial results, including net income of $32.4 million ($2.58 diluted EPS), net interest income of $97.6 million, and net interest margin expansion to 4.36%.
View raw filing on EDGAR →Standard Lithium disclosed a Preliminary Economic Assessment (PEA) for its Franklin Project in Texas, prepared by qualified independent engineers and metallurgists. The PEA evaluates the economic viability and technical feasibility of the mineral project, representing a significant operational and strategic milestone for the company's development pipeline.
View raw filing on EDGAR →This Item 8.01 filing is a supplemental disclosure amending and updating information in the proxy statement regarding the previously disclosed merger between DoubleVerify and Neptune BidCo US Inc. (parent of Nielsen). The filing updates regulatory approvals (German, Cypriot, Australian, and Moroccan clearances received), legal proceedings related to the merger, and post-closing employment arrangements. While technically filed under Item 8.01, the substance is clearly material M&A activity—the completion and regulatory status of a major acquisition that was entered into on August 6, 2026.
View raw filing on EDGAR →Ashford Hospitality Trust entered into two material definitive agreements on October 20, 2026: a Share Purchase Agreement with Ashford Inc. committing to quarterly open-market purchases of 2.5% of outstanding shares over up to three years, and a Limited Waiver waiving approximately $17 million in advisory fees over six months. These transactions are intended to strengthen the Company's liquidity and align the interests of its advisor with those of stockholders.
View raw filing on EDGAR →The Company terminated its At-the-Market equity distribution agreement dated April 11, 2022, which had permitted sales of up to $100 million in common stock. This termination eliminates a key liquidity tool and signals a strategic shift toward reliance on the advisor's share purchase commitment and fee waiver rather than direct equity offerings.
View raw filing on EDGAR →Northrop Grumman issued an earnings release on October 20, 2026, announcing third quarter 2026 financial results under Item 2.02. The release discloses quarterly sales of $11.1 billion (7% increase), net earnings of $1.1 billion, diluted EPS of $7.89, and raises 2026 full-year guidance for segment operating income and MTM-adjusted EPS. This is a standard quarterly earnings disclosure furnished as Exhibit 99, materially affecting investor assessment of the company's financial performance and outlook.
View raw filing on EDGAR →Insmed appointed two new independent directors effective October 19, 2026: Paul Hudson (former CEO of Sanofi and Novartis) and Utpal Koppikar (CFO of Verily Health). Both received committee assignments and equity compensation packages of approximately $585,000 in RSUs each, bringing significant executive experience to the board at a pivotal time for the company.
View raw filing on EDGAR →PDS Biotechnology appointed three new directors—Deborah A. Ramsdell, John A. Dawson CBE, and Bruce Wendel—to its Board of Directors effective October 18, 2026, bringing substantial pharma industry experience in drug development, commercialization, and M&A. The appointments occurred simultaneously with the resignation of four existing directors.
View raw filing on EDGAR →Freenome announced the launch of SimpleScreen™ Lung, a laboratory-developed blood-based test for lung cancer screening, and introduced a 'Personalized Cancer Detection' portfolio approach enabling dual screening for lung and colorectal cancer through a single blood draw. The lung cancer test demonstrated 85% sensitivity and 99.8% negative predictive value, representing a material product launch and portfolio expansion for the early-stage cancer detection company.
View raw filing on EDGAR →This is a clear earnings release disclosing quarterly and nine-month financial results for Farmers & Merchants Bancorp as of September 30, 2026. The press release reports record third-quarter net income of $25.1 million (up 5.75% YoY), diluted EPS of $36.75 (up 8.34% YoY), and provides comprehensive financial metrics including ROA, ROE, loan growth, deposit growth, and capital ratios. The disclosure is material to investors as it presents the company's operational and financial performance for the period.
View raw filing on EDGAR →This is a press release announcing Grupo Aeroportuario del Pacífico's consolidated financial results for the third quarter ended September 30, 2026. The document presents detailed quarterly revenue, operating costs, EBITDA, net income, and comprehensive income figures compared to the prior-year quarter, along with passenger traffic data and operational metrics. This is a discrete earnings announcement, not a periodic financial report filing, and is material to investors assessing the company's financial performance.
View raw filing on EDGAR →Standard Lithium announced the filing of a Preliminary Economic Assessment (PEA) for the Franklin lithium project in East Texas, a partnership with Equinor. The PEA discloses attractive project economics (NPV8 of $5.9 billion, IRR of 25.7%, 3-year payback) and contemplates 70,000 tonnes annual production capacity beginning in the early 2030s. This is a material operational/strategic milestone advancing the project toward a Preliminary Feasibility Study, representing significant progress on the company's flagship development initiative. While not a discrete M&A transaction or financial event, this project advancement would materially affect a reasonable investor's assessment of the company's near-term development prospects and value creation potential.
View raw filing on EDGAR →This press release announces FDA approval of a new manufacturing process for SIMLANDI® (adalimumab-ryvk) that more than doubles drug substance output per batch. While the disclosure involves regulatory approval, the core event is an operational/manufacturing milestone—process optimization and capacity expansion—rather than a discrete regulatory filing or approval of a new product. The announcement emphasizes manufacturing productivity gains and operational flexibility, making it an operational achievement rather than a financial, governance, or legal event. This is material to investors as it affects the company's ability to meet growing demand and optimize existing infrastructure.
View raw filing on EDGAR →Optimi announces completion of MDMA production batch to supply three programs: a proposed Phase 3 PTSD trial in Canada, a clinical trial in Israel with MAPS, and commercial export to Australia. This is a material operational milestone disclosing manufacturing completion, regulatory progress (Health Canada Drug Establishment Licence, Australian import permits), and advancement of clinical and commercial programs. While not a discrete M&A, financing, or executive event, the production completion and multi-jurisdictional supply arrangements represent material operational progress for a pharmaceutical manufacturer.
View raw filing on EDGAR →Cheryl Beranek, President and Chief Executive Officer and co-founder of Clearfield, Inc., is retiring effective March 31, 2027. The company has initiated a succession planning process to identify her replacement, and she will transition to a non-director CEO Emeritus role following her departure.
View raw filing on EDGAR →Stride, Inc. issued a press release on October 20, 2026 announcing its financial results for the first quarter of fiscal year 2027 ended September 30, 2026. The disclosure includes detailed quarterly financial metrics (revenue of $639.4 million, net income of $64.9 million, diluted EPS of $1.45), segment revenue data, enrollment metrics, cash flow information, and full-year fiscal 2027 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the company's financial performance and operational trends.
View raw filing on EDGAR →Nicolet Bankshares issued a press release on October 20, 2026, announcing third quarter 2026 earnings with net income of $64 million ($68 million core), diluted EPS of $2.96 ($3.15 core), and net interest margin expansion to 4.19%.
View raw filing on EDGAR →Nicolet's Board of Directors declared a quarterly cash dividend of $0.36 per share on common stock, payable December 15, 2026, to shareholders of record as of December 1, 2026.
View raw filing on EDGAR →Fort Technology's majority-owned subsidiary Logia USA has entered into an exclusive commercial distributorship agreement with SVL to expand fuel maintenance solutions across defined Midwest territories and parts of Illinois. This is a material operational/commercial milestone representing a significant step in Logia USA's U.S. commercialization strategy for its automated fuel integrity systems targeting data centers and mission-critical facilities. The agreement is effective October 12, 2026 through July 31, 2027, and the press release emphasizes it as "an important step in the commercialization" of these products.
View raw filing on EDGAR →This press release announces the launch of Uranus-Drones-V2, a new video and AI processing platform for drone applications. The Company explicitly states it "expects the platform to generate orders from existing and new customers," indicating a material product launch with commercial significance. While not fitting a discrete event category (not M&A, not a financial result, not an executive change), this is a significant operational/strategic milestone—a new product introduction expected to drive revenue—that would affect a reasonable investor's assessment of the registrant's growth prospects and market position.
View raw filing on EDGAR →This press release announces approximately $3 million in cash collections from service-related commissions in Decent's senior care business (Suncare) since September 2026. The disclosure describes commercial progress in a new business segment and revenue stream, representing a strategic operational milestone. While the company frames this as demonstrating "potential" and "commercial progress," the actual cash collections and the emphasis on this being a "meaningful commercial milestone" in developing a diversified business model constitute a material operational event that would inform a reasonable investor's assessment of the company's business development trajectory, even though it does not fit neatly into more specific event categories like earnings_release (which typically reports comprehensive financial results) or ma_activity.
View raw filing on EDGAR →This exhibit is a notice and proxy statement for a special shareholder meeting scheduled for November 10, 2026, to vote on approval of one or more reverse share splits (up to 1-for-250 cumulative ratio) at the Board's discretion within 18 months. While the document is soliciting votes rather than reporting results, it is a governance event requiring shareholder approval for a material capital structure change. The reverse split authorization is material as it affects share structure and could impact stock price, liquidity, and shareholder dilution. The document explicitly states voting results will be published in a subsequent Form 6-K, but this exhibit itself is the shareholder vote notice/proxy materials, which is governance-related and material.
View raw filing on EDGAR →Shinhan Financial Group completed a share repurchase program acquiring 6,538,515 treasury shares (1.39% of issued shares) for approximately KRW 700 billion between July 31 and October 16, 2026. Share repurchase programs are classified as a form of return of capital to shareholders under the dividend_distribution category, and the scale (nearly 1.4% of outstanding shares and ~700 billion KRW in capital deployed) is material to investor assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →Rapport announced positive topline results from a Phase 2 trial of RAP-219 for bipolar mania, meeting primary and secondary endpoints with statistically significant improvements in YMRS and CGI-BP scores and a favorable safety profile. This clinical development milestone establishes proof-of-concept for the company's lead candidate and supports progression to Phase 3 trials expected in H2 2027.
View raw filing on EDGAR →Odyssey Therapeutics disclosed completed Phase 2a clinical trial results for OD-001, its lead candidate for ulcerative colitis, presented at UEG Week 2026. The disclosure highlights positive efficacy data (primary endpoint met with p<0.001), favorable safety profile, and mechanistic evidence supporting continued development into Phase 2b and Phase 2a combination trials. This is a material clinical milestone for a clinical-stage biopharmaceutical company that would affect investor assessment of the company's pipeline progress and probability of success, though it does not fit neatly into earnings, M&A, governance, or financial obligation categories—making it an operational/strategic milestone best classified as operational_other.
View raw filing on EDGAR →Flutter Entertainment committed to a restructuring plan affecting its UK & Ireland business on October 20, 2026, resulting in up to 1,400 employee redundancies (approximately 15.6% of the 9,000 UK & Ireland workforce) with estimated pre-tax restructuring charges of $80–$90 million, primarily for severance and benefits, to be incurred in Q4 2026.
View raw filing on EDGAR →Vicor Corporation issued a press release on October 20, 2026 announcing financial results for the three and nine months ended September 30, 2026, disclosing product and royalty revenues of $197.1 million (up 78.5% year-over-year), net income of $63.3 million ($1.33 per diluted share), and backlog of $406 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the full press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →This is a clear earnings release disclosing Ally Financial's third quarter 2026 financial results. The Item 2.02 filing explicitly states "Ally Financial Inc. issued a press release announcing preliminary operating results for the third quarter ended September 30, 2026," with the press release attached as Exhibit 99.1. The disclosure includes GAAP EPS of $1.30 (up 10% YoY), pre-tax income of $567 million (up 11% YoY), and comprehensive segment and operational results, making this a material quarterly earnings announcement.
View raw filing on EDGAR →Prudential Financial announced entry into definitive agreements to sell 100% of its equity interests in Prudential of Brazil and Prudential of Mexico to CNP Assurances Group for approximately $4.025 billion in cash. This material disposition of significant business units represents a major strategic shift to exit emerging markets and redeploy capital, with expected closing in H2 2027.
View raw filing on EDGAR →The filing discloses the appointment of Andrew Raab as a director of StubHub Holdings, Inc., effective October 16, 2026, to fill an existing vacancy on the Board. While the disclosure also mentions prior transactions (Series O preferred stock purchase and consulting agreement), the principal action disclosed in this Item 5.02 is the director appointment itself, which is material to investors as it affects board composition and governance.
View raw filing on EDGAR →Newell Brands announced the appointment of Guillermo H. Beade as Chief Operating Officer, effective October 26, 2026. The disclosure details his background, reporting relationship to the CEO, and comprehensive compensation package including base salary of $830,000, bonus eligibility, and long-term incentive participation. This is a material executive appointment to a senior operational role with enterprise accountability for sales, marketing, and supply chain functions globally.
View raw filing on EDGAR →China Yuchai International announced the formation of a new joint venture, Guangxi Aobei Technology Company Ltd., between its wholly owned subsidiary Yuchai Foundry (34% stake, RMB 17 million) and Guangxi Zhenye (66% stake, RMB 33 million) to engage in austempered ductile iron (ADI) heat treatment and production of automotive components. This is a strategic operational and business development event combining the company's casting capabilities with a partner's ADI technology expertise to expand into a new product line for automotive applications.
View raw filing on EDGAR →Salesforce announced entry into a definitive agreement to acquire Braze for approximately $5.66 billion in enterprise value, with Braze shareholders to receive $47.50 per share in cash. This is a material acquisition disclosed via joint press release on October 20, 2026, representing a significant M&A transaction that would materially affect Salesforce's strategic position and financial profile.
View raw filing on EDGAR →The filing discloses a declared cash distribution to unitholders of $0.277908 per unit, payable November 16, 2026, to unitholders of record on October 30, 2026. This is a routine monthly distribution announcement by a royalty trust, which constitutes a dividend or distribution to security holders. The news release includes underlying oil and gas sales volumes and pricing data supporting the distribution calculation, typical of royalty trust disclosures.
View raw filing on EDGAR →The filing announces a monthly cash distribution to unitholders of $0.045191 per unit, payable on November 16, 2026. This is a routine but material dividend distribution by the Permian Basin Royalty Trust to its security holders, which is the primary substance of the Item 2.02 disclosure and the attached press release.
View raw filing on EDGAR →PermRock Royalty Trust declared a monthly cash distribution to unitholders of $197,140.34 ($0.016204 per Trust Unit), payable on November 16, 2026. The press release details the distribution amount, record date, payment date, and underlying production volumes and pricing that support the calculation. This is a routine but material distribution disclosure typical of royalty trusts, which are required to distribute substantially all cash flow to unitholders.
View raw filing on EDGAR →Hancock Whitney Corporation announced its third quarter 2026 financial results on October 20, 2026, disclosing net income of $110.1 million ($1.36 per diluted share) and adjusted EPS of $1.66, with comprehensive quarterly results including loan and deposit growth, net interest margin expansion, and capital ratios.
View raw filing on EDGAR →First Tracks Biotherapeutics closed a private placement of 6,106,870 shares of common stock on October 19, 2026, and entered into a registration rights agreement with the investors. This is a classic dilutive equity issuance—an unregistered sale of common stock to private investors with registration rights. The materiality is evident from the substantial share count and the company's obligation to register the shares for resale within 30 days, which signals a significant capital raise and shareholder dilution.
View raw filing on EDGAR →CSB Bancorp issued a news release on October 20, 2026 announcing third quarter 2026 earnings, disclosing net income of $4,987,000 ($1.90 per diluted share), a 20% increase from the prior year quarter. The filing includes detailed financial tables, performance metrics (ROA 1.50%, ROE 14.67%), and management commentary on results. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →State Street Corporation issued $750 million of Fixed-to-Floating Rate Senior Notes due 2037 in a public offering, and its subsidiary State Street Bank issued $1.25 billion in Bank Notes ($500 million floating rate and $750 million fixed rate due 2028), totaling approximately $1.99 billion in aggregate principal. These are direct creations of new financial obligations disclosed under Item 8.01, representing material debt capital raises that would affect investor assessment of the company's capital structure and liquidity.
View raw filing on EDGAR →Randall P. Gabe, Senior Vice President and Chief Administrative Officer, informed the Company of his intention to retire effective on or before June 1, 2027, after 30 years of service. Although he will transition to a new role (Senior Vice President/Business Development) until the Effective Date, the principal disclosed action is his departure from his current executive position and ultimate retirement from the Company. This is a material executive departure requiring 8-K disclosure under Item 5.02.
View raw filing on EDGAR →JPMorgan Chase closed public offerings of $7.0 billion in aggregate principal amount of floating-rate and fixed-to-floating-rate notes due 2030 and 2037. This constitutes creation of new direct financial obligations through debt issuance, a material capital-raising event for a major financial institution. The disclosure of the closing of registered public offerings of debt securities is a classic debt_issuance event.
View raw filing on EDGAR →Onex Direct Lending BDC Fund disclosed quarterly portfolio and business commentary including NAV per share of $17.04 (down 1.6% QoQ and 11.0% YTD), net investment income of $0.44/share, dividend distributions of $0.53/share at 12.44% annualized yield, and portfolio metrics showing 261.6M fair value across 43 companies with 97% first lien debt. The material decline in NAV and net unrealized depreciation driven by two portfolio companies make this disclosure material to investors assessing the fund's financial condition.
View raw filing on EDGAR →Scott M. Wasserman, MD was appointed as a Class III director and member of the Compensation Committee effective October 19, 2026, bringing significant clinical development expertise to support the Company's Phase 3 IMPROVE-PAH study. The appointment includes equity compensation of 310,000 stock options. Dennis Berman's concurrent resignation is noted but secondary to the forward-looking appointment.
View raw filing on EDGAR →The exhibit announces the appointment of Tim Cox as U.S. Country Head and CEO of BMO's U.S. subsidiaries, effective November 1, 2026, with a reporting line to the CEO and Executive Committee membership. While the announcement also mentions Darrel Hackett's transition to Executive Vice-Chair and Senior Advisor (a departure from his U.S. CEO role), the principal disclosed action is Cox's appointment to a material executive position overseeing BMO's U.S. operations. This is a significant leadership change at a major financial institution affecting governance and operational structure.
View raw filing on EDGAR →The Board of Directors appointed Gary Ferrera and Brian Krzanich as directors on October 14, 2026, expanding the board from seven to nine members. Both appointees bring substantial executive experience (Ferrera with 30+ years in financial leadership including multiple CFO roles; Krzanich with 40+ years in technology including CEO roles at three public companies), and Ferrera was appointed to the Audit Committee. This is a material governance event affecting board composition and oversight.
View raw filing on EDGAR →The filing explicitly discloses "substantial doubt about the Trust's ability to continue as a going concern" due to insufficient cash reserves, no distributions since July 2023, and cumulative excess costs totaling over $32 million across three conveyances. The Trustee states the Trust "may have to take drastic measures to continue to exist or alternatively may have to terminate" and is exploring asset sales or termination, with no assurance of recovery for unitholders. This is a terminal-level disclosure materially affecting investor assessment.
View raw filing on EDGAR →The Trust announced it will not declare a monthly cash distribution for October 2026 due to excess production costs and low natural gas pricing. While framed as a non-declaration, this is a material disclosure about the Trust's distribution policy—the primary mechanism by which it returns value to unitholders. The press release details the cumulative excess production costs ($12.4M gross), the conditions that must be met before distributions resume, and the underlying operational and financial constraints. For a royalty trust whose principal purpose is distributing cash to unitholders, suspension of distributions is a material event affecting investor returns.
View raw filing on EDGAR →